| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |